1.
Gynecol Oncol
; 26(2): 225-7, 1987 Feb.
Artículo
en Inglés
| MEDLINE
| ID: mdl-3804038
RESUMEN
Thirty evaluable patients with recurrent and/or metastatic cervical cancer were treated with a combination of cyclophosphamide, adriamycin, and cis-platinum. We observed no complete response and three partial responses (10%). One year survival rate was 45%. CAP combination did not prove to be more effective than single agent cis-platinum.